AUPH FY 2016 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$173,000-26.4% YoY

Gross Profit

$169,00097.7% margin

Operating Income

-$23M-13187.3% margin

Net Income

-$23M-13465.3% margin

EPS (Diluted)

$-0.66

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$57M

Total Liabilities

$21M

Stockholders' Equity

$36M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$173,000	$235,000	-26.4%
Gross Profit	$169,000	$223,000	-24.2%
Operating Income	-$23M	-$24M	+3.2%
Net Income	-$23M	-$19M	-25.2%